A unique pharmaceutical company

Orphan Europe, part of the Recordati group, is a unique pharmaceutical company focusing on the research and development of orphan medicinal products. Since 1990 we have used big thinking and extensive know-how on behalf of people affected by rare diseases. Patients and their families are central to our planning, our thinking and our actions. Recordati orphan drugs is present in the USA through its company Recordati Rare Diseases.

News and events

Orphan Europe - Carbaglu® A tailored and life-saving treatment
Read the article in the last issue of the EU Parliament Magazine

"Meet the Experts: Acute Porphyria in Practice"
Webcast for physicians interested in Porphyria
On 26 November 2014 at 1 PM UK time, 2 PM CET time.
For more information, please click here.